About Passage Bio (PASG)
Passage Bio Inc is a preclinical stage genetic medicines company. The Company is focused on developing transformative therapies for rare, monogenic central nervous system (CNS). The Company is developing a portfolio of six life transforming AAV-deliv... Read more
- USD0.33
- USD0.42
- USD0.33
- USD1.64
- 1.00%
- --
- 431.84k
- 212.43k
- 20M
- 0.30
- -70.50%
Stock News
5 hours ago
Franklin Equity Income SMA Q1 2025 Commentary
SeekingAlpha
yesterday
Oil prices sink as OPEC+ hikes output, U.S. stock futures dip ahead of Fed meeting
MarketWatch
yesterday
NPR and PBS CEOs say they'll challenge Trump administration over federal funding cuts
CNBC
yesterday
Aquestive Therapeutics: Unprofitable For A Few More Years, But Significant Upside Potential
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
